|
Vivas D, Anguita-Gamez M, Ferrandis R, Esteve-Pastor MA, Echeverri M, Igualada J, Anguita M, Egocheaga I, Nozal-Mateo B, Abad-Motos A, Figuero E, Bouzo-Molina N, Lozano T, Alvarez-Ortega C, Torres J, Descalzo MJ, Catala JC, Martin-Rioboo E, Molines A, Rodriguez-Contreras R, Carnero-Alcazar M, Marin F; REQXAA study investigators. Prospective observational registry of perioperative and periprocedural management of antithrombotic therapy in "real world": the REQXAA study. Rev Esp Cardiol (Engl Ed). 2023 Sep;76(9):729-738. doi: 10.1016/j.rec.2023.03.003. Epub 2023 Mar 11. English, Spanish. PubMed PMID: 36914025.
AÑO: 2023; IF: 5.9
|
36914025
|
Martinez-Montesinos L, Rivera-Caravaca JM, Agewall S, Soler E, Lip GYH, Marin F, Roldan V. Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity? Biomed Pharmacother. 2023 Feb;158:114064. doi: 10.1016/j.biopha.2022.114064. Epub 2022 Dec 7. PubMed PMID: 36495662.
AÑO: 2023; IF: 6.9
|
|
Ding WY, Romero-Aniorte AI, Tello-Montoliu A, Gil-Perez P, Lopez-Garcia C, Veliz-Martinez A, Quintana-Giner M, Lip GYH, Rivera-Caravaca JM, Marin F. Simplified Geleijnse score for identifying chest pain features associated with coronary ischemia. Heart Lung. 2023 May-Jun;59:61-66. doi: 10.1016/j.hrtlng.2023.01.010. Epub 2023 Feb 3. PubMed PMID: 36739642.
AÑO: 2023; IF: 2.4
|
|
Hochman JS, Anthopolos R, Reynolds HR, Bangalore S, Xu Y, O'Brien SM, Mavromichalis S, Chang M, Contreras A, Rosenberg Y, Kirby R, Bhargava B, Senior R, Banfield A, Goodman SG, Lopes RD, Pracon R, Lopez-Sendon J, Maggioni AP, Newman JD, Berger JS, Sidhu MS, White HD, Troxel AB, Harrington RA, Boden WE, Stone GW, Mark DB, Spertus JA, Maron DJ; ISCHEMIA-EXTEND Research Group. Survival After Invasive or Conservative Management of Stable Coronary Disease. Circulation. 2023 Jan 3;147(1):8-19. doi: 10.1161/CIRCULATIONAHA.122.062714. Epub 2022 Nov 6. PubMed PMID: 36335918; PubMed Central PMCID: PMC9797439.
AÑO: 2023; IF: 35.5
|
|
Nunez-Gil IJ, Feltes G, Viana-Llamas MC, Raposeiras-Roubin S, Romero R, Alfonso-Rodriguez E, Uribarri A, Santoro F, Becerra-Munoz V, Pepe M, Castro-Mejia AF, Signes-Costa J, Gonzalez A, Marin F, Lopez-Pais J, Cerrato E, Vazquez-Cancela O, Espejo-Paeres C, Lopez Masjuan A, Velicki L, El-Battrawy I, Ramakrishna H, Fernandez-Ortiz A, Perez-Villacastin J; HOPE-2 Investigators. Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2). J Clin Med. 2023 Jan 16;12(2):706. doi: 10.3390/jcm12020706. PubMed PMID: 36675633; PubMed Central PMCID: PMC9863454.
AÑO: 2023; IF: 3.0
|